Vaginal atrophy can lead to an array of complaints in post-menopausal women including vaginal dryness, pain with intercourse, frequent urinary tract infections, and vaginal itching and burning. Prior first-line therapies for treatment of atrophic vaginitis were non-hormonal vaginal lubricants and moisturizers or hormonal estrogen replacement with either systemic or topical agents. Vaginal estrogen cream is an effective treatment option, however, it can be costly, inconvenient, and is contraindicated in patients with a history of breast or gynecologic cancers.
The US Food and Drug Administration (FDA) recently approved a CO2 laser for the treatment of vaginal atrophy called the MonaLisa Touch. Treatment with this vaginal laser promotes a return of the vaginal wall to a premenopausal state. The treatment consists of three 5-10 minute sessions spaced six weeks apart followed by a yearly maintenance treatment. Below are microscopic images taken from vaginal tissue before and after two treatments with the MonaLisa Touch Vaginal Laser. Notice the thin top layer on the before image compared to the thick vaginal epithelium on the post-treatment image.
In addition to objective changes in the vaginal tissue, studies have shown improvement in symptoms related to vaginal atrophy following treatment with the MonaLisa Touch Vaginal Laser. A recent study from Italy found improvement in vaginal dryness, itching, and dysuria following 3 treatment sessions which is illustrated in the following graph:
Learn More about MonaLisa Touch
Regional Urology is proud to offer this state of the art technology for treating women with post-menopausal vaginal atrophy and we continue to see how it improves the quality of life for women in the Ark-La-Tex!